The Ad26.Mos4.HIV vaccine – which uses the same adenoviral technology as J&J's COVID-19 vaccine and targets four HIV antigens – showed that the shot was safe but unable to meet its target of ...
There were 35 eyes of 33 patients, with a mean age of 68.2±19.5 years (range: 17–99 years). There were 25 men and 8 women. Median follow-up was 110 days (mean: 164.6 days; range: 30–960 days).